CFCThe Compounder Score

Discover the
Compounder Score

A high-ROCE framework built to beat the S&P 500 with less downside risk, with every company evaluated on the following criteria.

Scroll

0+

Companies analyzed

Each one audited with our 22-point Compounder Score.

0+

Valuation alerts in the last 3 months

Times a company we cover entered its buy zone.

Best-in-Class vs the S&P 500

What if you bought every Best-in-Class company at its first valuation alert?

Loading the scenario...

Backed by real examples

Every purchase in the chart above, one by one.

Loading the purchases...

Four steps behind every buy signal

The same repeatable process, applied to every company we cover.

Score every company

A 22-point audit of returns on capital, growth, margins and balance sheet.

Loading the scorecard...

Understand the moat

A written deep dive on why the advantage lasts, published before any buy order.

Browse the research library
Deep-dive thesisPublished
Equity deep dive: Samsara

Samsara (IOT): The Moat Operating System for Physical Operations

Nov 29, 202523 min read

Price in a margin of safety

Three valuation scenarios, with a safety margin built into every buy price.

Loading the valuation...

Get alerted at the right price

An email and in-app alert when a stock reaches a buy target, so you can build a position in three tranches.

Buy alertsSample

NYAX crossed Buy Price 1 ($21.50)

Tranche 1 entry triggered

Delivered automatically by

Emailalerts@thecashflowcompounder.com
In-appAlerts inbox in your account

Illustrative example. An alert says a target was reached; you decide whether to place the order.

Start free, go deeper when you're ready

Institutional-grade fundamental tools, without the institutional price.

Explorer

Guest

$0/mo

No account needed.

No sign-up, no email:

  • Fundamentals for any listed stock
  • Price chart vs the S&P 500
  • Revenue and margin charts
  • Cash flow charts
  • 3-scenario DCF (view only)
Explore a stock

Investor

Free subscriber

$0/mo

Free forever. Just create an account.

Everything in Explorer, plus:

  • Fundamentals tables, every covered stock
  • Request a review of any company
  • Weekly newsletter write-ups
Full access

Compounder

Paid subscriber

~$12/mo

Billed monthly, ~$144 a year

Everything in Investor, plus:

  • Full deep-dive research library
  • Unlimited Compounder Score lookups
  • 10+ years of financials
  • Interactive DCF sliders
  • Ready-to-Buy Watchlist, live prices
  • 3-tranche buy alerts (email, webhook)
  • Our live portfolio, every transaction
  • Priority queue: request any ticker
  • Private investor community
  • Downloadable Excel DCF models
Become a Compounder

Trusted by serious investors

Feedback from private investors, analysts and fund managers who use our methodology.

“The ROCE screen alone saved me from three value traps this year. Every candidate that clears the 20% threshold has actually held up operationally.”
MFMarcus Feld@CompoundInvestor
“I run a small fund and still use this as a second opinion. The margin-of-safety targets on the DCF are conservative in exactly the right way.”
PAPriya Anand@CapAllocationPro
“Tranche alerts changed how I enter positions. No more staring at charts wondering if today is the day — the system tells me when price actually earns the buy.”
DODaniel Osei@QualityCompounders
“The 22-point audit is the most complete quality checklist I have seen outside an institutional research desk. Buybacks and debt get equal weight to growth.”
LBLaura Bennett@ValueWithLaura
“Free cash flow CAGR is the only growth metric that has ever mattered to me, and this is the first screener that puts it front and center.”
THTomás Herrera@FCFHunter
“I am a patient, low-turnover investor and this platform respects that. It never pressures you — it just tells you clearly when your target price has arrived.”
GWGrace Whitfield@SlowMoneyGrace
“Ran my entire existing portfolio through the scorecard and found two names quietly deteriorating on capital efficiency I would not have caught for a year otherwise.”
KWKenji Watanabe@ROCEFirst
“The three-scenario DCF is the reason I finally stopped anchoring on a single fair value number. Seeing Bear/Base/Bull side by side makes uncertainty honest.”
SMSofia Mercer@MarginOfSafetySof
“Six months in and the buy-zone alerts have fired exactly twice — which is precisely the point. This is not a tool that wants you trading every day.”
OBOwen Baptiste@LongOnlyOwen
“What sold me was the moat write-ups alongside the numbers. A great ROCE with no structural reason to persist is just a coincidence, and this tool treats it that way.”
EVElena Vasquez@CashFlowElena

Every company we have analyzed

Pick a company to see its Compounder Score, price and research.

Questions, answered clearly

Think of it as a 22-point health inspection for businesses. Instead of guessing whether a stock is good, the score checks return on capital (ROCE above 15%), free cash flow growth, debt safety and share count discipline, and gives you one clear rating out of 22.

Read the full methodology